InnovAge Holding Corp (INNV) FinancialsINNVInnovAge Holding Corp

InnovAge Holding Corp (INNV) generates its revenue primarily from Pace, which accounts for 100.0% of total sales, equivalent to $261.95M. Understanding this concentration is critical for investors evaluating how INNV navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, InnovAge Holding Corp maintains a gross margin of 21.44%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.13%, while the net margin is 3.73%. These profitability ratios, combined with a Return on Equity (ROE) of -1.08%, provide a clear picture of how effectively INNV converts its operational activities into shareholder value.

In the context of the broader market, INNV competes directly with industry leaders such as RDVT and SECZ. With a market capitalization of $1.24B, it holds a significant position in the sector. When comparing efficiency, INNV's gross margin of 21.44% stands against RDVT's 75.28% and SECZ's N/A. Such benchmarking helps identify whether InnovAge Holding Corp is trading at a premium or discount relative to its financial performance.

InnovAge reported a total revenue of $989.7 million for fiscal year 2026, a 15.9% increase year-over-year, and an adjusted EBITDA of $94.6 million, up 174.2%, indicating strong operational performance.